ICRM
MRK icon

Insight Capital Research & Management’s Merck MRK Stock Holding History

Insight Capital Research & Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-46,503
Closed -$2.06M – 195
2013
Q2 		$2.06M Buy
+46,503
New +$2.08M 0.53% 67

Other funds holding MRK

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Insight Capital Research & Management's MRK Position: Q3 2013 in Review

Insight Capital Research & Management sold out of Merck (MRK) in Q3 2013, closing a stake of 46,503 shares — an estimated $2.06M sold.

Insight Capital Research & Management first reported a position in MRK in Q2 2013 and held it in 1 quarter. The position peaked at $2.06M in Q2 2013. 1,470 funds tracked by Wall St. Rank hold MRK as of Q3 2013.

  • Insight Capital Research & Management reported no remaining Merck position as of Q3 2013 after selling out during the quarter.
  • Insight Capital Research & Management sold 46,503 Merck shares in Q3 2013, an estimated $2.06M.
  • Insight Capital Research & Management first reported a position in Merck in Q2 2013 and held it in 1 quarter.
  • Insight Capital Research & Management's Merck position peaked at $2.06M in Q2 2013.
  • 1,470 funds tracked by Wall St. Rank held Merck as of Q3 2013.

Based on Insight Capital Research & Management's 13F filing for Q3 2013, filed 13 Nov 2013.